Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “corporate” rating reiterated by N+1 Singer in a note issued to investors on Monday.

EKF has been the subject of a number of other research reports. FinnCap restated an “under review” rating on shares of Ekf Diagnostics Holding PLC in a research report on Tuesday, November 29th. Panmure Gordon restated a “buy” rating and set a GBX 21 ($0.26) price objective on shares of Ekf Diagnostics Holding PLC in a research report on Thursday, January 26th.

Ekf Diagnostics Holding PLC (LON:EKF) opened at 21.50 on Monday. The firm’s market capitalization is GBX 99.61 million. Ekf Diagnostics Holding PLC has a 12 month low of GBX 9.48 and a 12 month high of GBX 21.88. The company has a 50 day moving average price of GBX 20.20 and a 200 day moving average price of GBX 17.99.

COPYRIGHT VIOLATION WARNING: “N+1 Singer Reaffirms “Corporate” Rating for Ekf Diagnostics Holding PLC (EKF)” was first published by Marea Informative and is the sole property of of Marea Informative. If you are viewing this report on another website, it was stolen and reposted in violation of U.S. and international copyright law. The legal version of this report can be accessed at http://www.mareainformativa.com/n1-cantante-reafirma-corporativa-de-calificacion-para-ekf-diagnostics-holding-plc-ekf/108790/.

In related news, insider Christopher H. B. Mills purchased 8,000,000 shares of the company’s stock in a transaction that occurred on Monday, March 20th. The stock was bought at an average price of GBX 19 ($0.24) per share, for a total transaction of £1,520,000 ($1,913,152.93).

Ekf Diagnostics Holding PLC Company Profile

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company’s point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases.

Receive News & Stock Ratings for Ekf Diagnostics Holding PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekf Diagnostics Holding PLC and related stocks with our FREE daily email newsletter.